StockWatch
·

Concord Control Systems Ltd

BSE: 543619

P/L Snapshot

Q2 FY26 · standalone

vs Q4 FY25·vs Q2 FY25
Revenue
29.75
-26.3%-20.6%
Expenditure
21.97
-28.6%-19.2%
Net Profit
6.26
-17.2%-16.5%
OPM %
16.66%
-0.36pp-7.77pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0044.8589.70134.54179.39Q2 FY27Q2 FY24Q4 FY24Q2 FY25Q4 FY25Q2 FY26
Price Chart
Reports

₹159 Crore Surge, But Platforms Still in Beta

railway_tech · kavach_safety · hydrogen_propulsion

Result verdictFollow-upQ2 FY2711 Nov 20266 minIndustrials & Infra

95% revenue surge on record order book, but platforms early-stage

railway_tech · order_visibility · green_mobility

TranscriptDeep diveQ2 FY2711 Nov 20266 minIndustrials & Infra

Concord Control H1 FY27 PAT +95% YoY to ₹31.2 Cr, revenue nearly doubles

railway technology · kavach safety systems · order book

ResultsQ2 FY2702 Nov 20263 minIndustrials & Infra
Latest
Quarterly Result2 Nov, 3:22 pm

Concord Control H1 FY27 PAT +95% YoY to ₹31.2 Cr, revenue nearly doubles

Concord Control Systems reported consolidated PAT (attributable to owners) of ₹31.23 Cr for H1 FY27 (half year ended 30-Sep-2026), up 94.95% YoY from ₹16.02 Cr in H1 FY26, on consolidated revenue from operations of ₹159.11 Cr, up 95.12% YoY from ₹81.55 Cr. Standalone tells a close but not identical story: standalone PAT of ₹32.86 Cr (+90.27% YoY) is nominally higher in absolute rupees than the consolidated attributable figure — the gap is explained by a ₹1.12 Cr consolidated share-of-loss from two equity-method associates (Progota India Private Ltd, Concord Lab to Market Innovations Private Ltd) plus higher consolidated operating costs, partly offset by a minority-interest credit of ₹0.13 Cr tied to subsidiary Fusion Electronics. Consolidated is the primary basis per our convention; standalone is the secondary read. Margins were essentially flat YoY on the primary consolidated basis: net profit margin was 19.38% of total income versus 19.30% a year ago. EBITDA (PBT plus finance cost and depreciation) works out to roughly ₹46.7 Cr, a margin of about 29.3% of revenue — above the 20-25% EBITDA band management guided to at the Q4 FY26 concall (14-May-2026). Finance cost rose to ₹3.18 Cr consolidated from ₹0.54 Cr, and depreciation to ₹2.16 Cr from ₹1.09 Cr, both scaling with the balance sheet (short-term borrowings up to ₹70.97 Cr from ₹39.15 Cr at FY26-end), but neither dented the overall margin. No formal street/analyst estimates for this quarter could be located — Concord trades at a market cap in the low thousands of crores with limited broker coverage, so vsStreet is marked unknown rather than invented. Against management's own prior guidance (Q4 FY26 concall: 40-50% revenue CAGR off a then-record ₹697 Cr executable order book with an 18-24 month execution cycle, and a 20-25% EBITDA margin target), this print is a clear beat — ~95% YoY revenue growth is well ahead of the guided CAGR range, and the ~29% EBITDA margin sits above the guided band. No separate management press release was available for this filing (board outcome letter and the two Annexure statements plus limited-review reports were the only documents); the only this-quarter corporate markers on record are procedural — the 02-Nov-2026 board meeting that approved these results and a scheduled 29-Oct-2026 post-results concall, which should give the first direct management commentary on this print. Working capital moved in the growth-funded direction management flagged: consolidated trade receivables stood at ₹140.76 Cr (from ₹121.19 Cr at FY26-end) and inventories at ₹104.08 Cr (from ₹88.59 Cr), funded partly by higher short-term borrowings, consistent with the 'growth-related working capital needs' management cited alongside its CAGR guidance.

2 Nov 2026, 03:22 pm

Corporate Events

Board MeetingCNCRD
2026
2Nov

Board Meeting

To consider and approve the Unaudited Financial Results (Sta…

BSE Filing ↗
Board MeetingCNCRD
2026
30Sep

Board Meeting

The 16th Annual General Meeting ("AGM") of the Shareholders …

BSE Filing ↗
Board MeetingCNCRD
2026
7Sep

Board Meeting

The Board of Directors considered and approved the appointme…

BSE Filing ↗
Board MeetingCNCRD
2026
17Aug

Board Meeting

The Board will consider and approve the migration of the com…

BSE Filing ↗
Board MeetingCNCRD
2025
25Nov

Board Meeting

consider and approve Intimation of Board, proposal for fund …

BSE Filing ↗
Board MeetingCNCRD
2025
27Jun

Board Meeting

Voting Result

BSE Filing ↗
Board MeetingCNCRD
2024
14Nov

Board Meeting

Consider and approve the unaudited Financial Results (Standa…

BSE Filing ↗
Board MeetingCNCRD
2024
2Sep

Board Meeting

Consider and approve the proposal for fund raising by way of…

BSE Filing ↗
Board MeetingCNCRD
2024
28May

Board Meeting

To consider and approve the Audited Financial Results (Stand…

BSE Filing ↗
Board MeetingCNCRD
2023
8Nov

Board Meeting

To consider and approve the Unaudited Financial Results (Sta…

BSE Filing ↗
Board MeetingCNCRD
2023
13Sep

Board Meeting

Inter alia consider a proposal for issuance of equity shares…

BSE Filing ↗